It would be important to reassess this pattern now with more widespread adoption of GLP-1s for obesity alone, since the study period ended in 2022
Knowing that profile before starting is the "test before you invest" approach an informed conversation with your provider, never a self-calculated dose
Women with PCOS may notice more regular cycles, better energy, and even improved skin and reduced facial hair
Prescription Benefit Enhancement Oklahoma Complete Health is expanding the prescription benefit to improve access to care
Most compounding pharmacies include preservatives in their multi-dose tirzepatide vials, but the specific preservative system and concentration vary, which contributes to BUD variation
June 28, 2024: Study Reveals Potential Bone Density Reduction with GLP-1 Treatment In a recent study, Simon Jensen, Ph.D., and others found that GLP-1 treatment, without exercise, could lead to reduced bone density